Janus Henderson Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $651K | Hold |
46,900
| – | – | ﹤0.01% | 1889 |
|
|
2025
Q4 | $761K | Hold |
46,900
| – | – | ﹤0.01% | 1817 |
|
|
2025
Q3 | $702K | Hold |
46,900
| – | – | ﹤0.01% | 1849 |
|
|
2025
Q2 | $546K | Hold |
46,900
| – | – | ﹤0.01% | 1903 |
|
|
2025
Q1 | $359K | Hold |
46,900
| – | – | ﹤0.01% | 2124 |
|
|
2024
Q4 | $281K | Buy |
+46,900
| New | +$259K | ﹤0.01% | 2278 |
|
|
2024
Q2 | – | Sell |
-42,686
| Closed | -$137K | – | 2520 |
|
|
2024
Q1 | $137K | Buy |
42,686
+6
| +0% | +$23 | ﹤0.01% | 2482 |
|
|
2023
Q4 | $209K | Sell |
42,680
-105
| -0.2% | -$479 | ﹤0.01% | 2421 |
|
|
2023
Q3 | $233K | Buy |
42,785
+7
| +0% | +$46 | ﹤0.01% | 2310 |
|
|
2023
Q2 | $287K | Sell |
42,778
-2
| -0% | -$15 | ﹤0.01% | 2270 |
|
|
2023
Q1 | $377K | Buy |
42,780
+24,161
| +130% | +$213K | ﹤0.01% | 2175 |
|
|
2022
Q4 | $142K | Sell |
18,619
-18,617
| -50% | -$145K | ﹤0.01% | 2267 |
|
|
2022
Q3 | $266K | Buy |
37,236
+18,589
| +100% | +$175K | ﹤0.01% | 2267 |
|
|
2022
Q2 | $151K | Buy |
18,647
+37
| +0.2% | +$325 | ﹤0.01% | 2393 |
|
|
2022
Q1 | $258K | Sell |
18,610
-368
| -2% | -$5.79K | ﹤0.01% | 2311 |
|
|
2021
Q4 | $532K | Buy |
18,978
+8,755
| +86% | +$268K | ﹤0.01% | 1856 |
|
|
2021
Q3 | $347K | Buy |
+10,223
| New | +$370K | ﹤0.01% | 1813 |
|
|
2021
Q1 | – | Sell |
-7,089
| Closed | -$419K | – | 1554 |
|
|
2020
Q4 | $419K | Buy |
+7,089
| New | +$366K | ﹤0.01% | 1290 |
|
|
2019
Q3 | – | Sell |
-248,900
| Closed | -$12M | – | 1400 |
|
|
2019
Q2 | $12M | Buy |
+248,900
| New | +$11M | 0.01% | 913 |
|
Other funds holding ADPT
VCM
VPM
